We are live on ! Find out more
TFFP

TFF Pharmaceuticals, Inc. Common Stock
TFFP

Delisted

TFFP was delisted on the 12th of December, 2024.

Back to rankings

15 hedge funds and large institutions have $5.08M invested in TFF Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$2.69M
2
PM
Precept Management
Texas
+$751K
3
MFIM
Mesirow Financial Investment Management
Illinois
+$321K
4
Millennium Management
Millennium Management
New York
+$286K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$267K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$2.81M +$2.69M +21,000 New
PM
2
Precept Management
Texas
$783K +$751K +5,852 New
MFIM
3
Mesirow Financial Investment Management
Illinois
$334K +$321K +2,500 New
Millennium Management
4
Millennium Management
New York
$299K +$286K +2,232 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$278K +$267K +2,081 New
BFM
6
Boothbay Fund Management
New York
$133K +$128K +995 New
SMH
7
Sanders Morris Harris
Texas
$101K +$97K +756 New
Goldman Sachs
8
Goldman Sachs
New York
$85K +$81.5K +635 New
BRWA
9
B. Riley Wealth Advisors
Florida
$73K +$69.3K +540 New
BlackRock
10
BlackRock
New York
$67K +$63.9K +498 New
SPC
11
Sigma Planning Corp
Michigan
$56K +$53.9K +420 New
Wells Fargo
12
Wells Fargo
California
$42K +$40.5K +316 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$11K +$10.3K +80 New
Morgan Stanley
14
Morgan Stanley
New York
$11K +$10.5K +82 New
UBS Group
15
UBS Group
Switzerland
$3K +$2.57K +20 New

TFFP Hedge Fund Activity: Q4 2019 in Review

15 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q4 2019, worth a combined $5.08M.

Buyers outnumbered sellers: 15 funds opened new TFFP positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $2.69M.

  • 15 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $5.08M of TFF Pharmaceuticals, Inc. Common Stock stock for Q4 2019.
  • 15 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +15 holders.
  • The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q4 2019 was Nantahala Capital Management, an estimated $2.69M added.

Based on aggregated 13F filings for Q4 2019.